Results overview: Found 1 records in 0.25 seconds.
Articles, 1 records found
Articles 1 records found  
1.
20 p, 3.0 MB Pilot, double-blind, randomized, placebocontrolled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity / Montané Esteva, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Barriocanal, Ana María (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Arellano, Ana Lucía (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Valderrama, Angelica (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sanz, Yolanda (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez-Álvarez, Núria (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Cardona, Paula (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vilaplana, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cardona, Pere-Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Background. Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-like lesions. [...]
2017 - 10.1371/journal.pone.0171294
PloS one, february 2017, p. 1-20  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.